Patents
Literature
19 results about "Liver targeting" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Liver Targeting. VLX103, is a novel oral form of pentamidine specifically designed to target the liver and minimize exposure to non-target, non-hepatic, organs and tissues.